Sex Subgroup Analysis of Treatment Response to Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
McGough, James J. [1 ,2 ]
Greenbaum, Michael [3 ]
Adeyi, Ben [4 ]
Babcock, Thomas [4 ]
Scheckner, Brian [4 ]
Dirks, Bryan [4 ]
Findling, Robert L. [5 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Capstone Clin Res, Libertyville, IL USA
[4] Shire Dev Inc, Wayne, PA USA
[5] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 32卷 / 01期
关键词：
CLINICAL-TRIALS; MODERATORS; ADHD;
D O I：
10.1097/JCP.0b013e318240dc53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 140
页数：4
相关论文
共 50 条
  • [21] Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
    Weisler, Richard H.
    Adler, Lenard A.
    Kollins, Scott H.
    Goodman, David W.
    Hamdani, Mohamed
    Dirks, Bryan
    Childress, Ann C.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1 - 12
  • [22] Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Lloyd, Eric
    Jacobsen, Leslie
    Gunawardhana, Lhanoo
    Johnson, Steven A., Jr.
    Findling, Robert L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (12) : 1423 - 1434
  • [23] Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen S.
    Civil, Richard
    Dauphin, Matthew
    Higgins, Nicholas
    Lyne, Andrew
    Gasior, Maria
    Squires, Liza A.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (06) : 647 - 657
  • [24] Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study
    Turgay, Atilla
    Ginsberg, Lawrence
    Sarkis, Elias
    Jain, Rakesh
    Adeyi, Ben
    Gao, Joseph
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Richards, Cynthia
    Lasser, Robert
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 503 - 511
  • [25] Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder
    Gordon, Chanelle T.
    Fabiano, Gregory A.
    Hulme, Kevin F.
    Sodano, Sandro M.
    Adragna, Michael
    Lim, Rachel
    Stanford, Samantha
    Janikowski, Leah
    Bufalo, Bradley
    Rodriguez, Zulema
    Swiatek, Denise
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2021, 29 (04) : 308 - 318
  • [26] Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity
    Ginsberg, Lawrence
    Katic, Alain
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Lasser, Robert
    Scheckner, Brian
    Adler, Lenard A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1097 - 1107
  • [27] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Dittmann, Ralf W.
    Cardo, Esther
    Nagy, Peter
    Anderson, Colleen S.
    Adeyi, Ben
    Caballero, Beatriz
    Hodgkins, Paul
    Civil, Richard
    Coghill, David R.
    CNS DRUGS, 2014, 28 (11) : 1059 - 1069
  • [28] Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    David R. Coghill
    Tobias Banaschewski
    Michel Lecendreux
    Alessandro Zuddas
    Ralf W. Dittmann
    Isabel Hernández Otero
    Richard Civil
    Ralph Bloomfield
    Liza A. Squires
    European Child & Adolescent Psychiatry, 2014, 23 : 61 - 68
  • [29] Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Zuddas, Alessandro
    Dittmann, Ralf W.
    Otero, Isabel Hernandez
    Civil, Richard
    Bloomfield, Ralph
    Squires, Liza A.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2014, 23 (02) : 61 - 68
  • [30] Adverse Events in Medication Treatment-Naive Children with Attention-Deficit/Hyperactivity Disorder: Results from a Small, Controlled Trial of Lisdexamfetamine Dimesylate
    Wigal, Sharon B.
    Wong, Amanda A.
    Jun, Angela
    Stehli, Annamarie
    Steinberg-Epstein, Robin
    Lerner, Marc A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (02) : 149 - 156
12345